SAFE vs CCD vs Priced Round: A Founder's Choice

Every founder, before their first round, asks the same question: SAFE, convertible note, or priced round? The honest answer is none of those names actually apply cleanly in India. SAFEs are a US construct that does not survive contact with FEMA. Convertible notes have a very narrow Indian carve-out. What you actually choose between, in the Indian market, is CCD, CCPS, or a priced equity round — with a SAFE-style instrument occasionally workable for early foreign-only rounds. Each has different tax, FEMA and control implications, and the wrong choice in your first round costs you for five years.

The four instruments compared

Set aside the marketing names. What you have are four distinct instruments: SAFE (Simple Agreement for Future Equity, US-style), Convertible Note (debt that converts on a trigger event), CCD (Compulsorily Convertible Debenture under Companies Act 2013) and CCPS (Compulsorily Convertible Preference Shares). Then there is the priced round — straight equity at a fixed valuation. Each handles dilution, tax, control and FEMA differently.

SAFE — fast, deferred dilution, but FEMA-fragile in India

A SAFE is a contractual right to future equity, with no interest, no maturity, no debt classification. Brilliant in the US: founders raise $500K from five angels in a week, no valuation negotiation, no document marathon. The instrument converts at the next priced round at a discount or cap.

The Indian problem: a SAFE is not a recognised instrument under FEMA NDI Rules. The list of permissible foreign investment instruments is closed — equity, CCDs, CCPS, warrants — and SAFE is not on it. Indian-resident investors can technically hold SAFE-style instruments since they are contractual, but practically every founder who takes significant SAFE money from foreign investors has to retroactively convert those SAFEs into CCDs or CCPS at the time of the first FEMA-compliant priced round, which re-opens negotiation on the conversion terms.

When a SAFE-style instrument can work in India: small Indian-resident-only seed rounds where speed beats structure, or rounds done into a foreign holding company (Delaware, Singapore) that later flips to India. For pure Indian-entity rounds with foreign investors, skip it.

CCD — the Indian standard convertible

A Compulsorily Convertible Debenture is the workhorse of Indian seed and bridge financing. Issued under Section 71 of Companies Act 2013, it is technically debt — but because it must convert into equity within ten years (and almost always within 18-36 months in practice), FEMA NDI Rules treat it as equity for foreign investment purposes. This makes CCDs the cleanest foreign-investor-friendly convertible instrument for Indian companies.

Structure: principal amount, optional coupon (often 0.01% to satisfy debenture characterisation), conversion trigger (usually the next priced round above a threshold), conversion terms (valuation cap, discount, or both), and a longstop date for mandatory conversion. The debenture trustee requirement for non-listed CCDs was relaxed in 2021 — making CCDs much simpler than they used to be.

The catch: CCDs require Section 42 private placement compliance under Companies Act, including a board-approved offer letter (PAS-4), a separate bank account for application money, and PAS-3 filing within 15 days of allotment. Skip these and the issuance is technically void.

CCPS — the senior cousin of CCD

Compulsorily Convertible Preference Shares are the instrument of choice for institutional seed and Series A investors in India. Same FEMA-friendly status as CCDs (treated as equity), but as preference shares they carry a liquidation preference — investors get paid out before equity holders in any liquidation event, up to the preference amount.

CCPS allows for sophisticated rights design that CCDs cannot match: anti-dilution adjustments (broad-based or full-ratchet), dividend rights, conversion ratio adjustments, voting on specific reserved matters, and consent rights on key corporate actions. This is the instrument for institutional investors who want preference economics without the debt classification of a CCD.

Trade-off: CCPS is more complex to issue (requires alteration of articles, separate class of shares, more elaborate shareholder approvals) and creates a layered cap table that must be cleaned up before any IPO. CCDs are simpler, CCPS is more powerful.

Priced round — what actually happens

A priced round is straight equity at a fixed pre-money valuation. No conversion mechanics, no caps, no discounts — just a number on day one. Used at Series A and later, where investor diligence supports a fixed valuation and the investor wants the cleanest possible position on the cap table.

The mechanics: pre-money valuation × (1 / (1 + dilution)) = price per share. Number of shares issued = investment / price per share. Post-money cap table reflects the new shareholder at the agreed dilution percentage. Standard term sheet terms — liquidation preference (1× non-participating is the Indian standard), anti-dilution (broad-based weighted average), board seat at thresholds, pre-emptive rights, drag-along, tag-along, ROFR.

Priced rounds are typically structured through CCPS in India (rather than direct equity) for two reasons: liquidation preference is easier to enforce on a preference share than on equity, and conversion ratio adjustments for anti-dilution are mechanically simpler. The economic effect is the same as straight equity, but the legal vehicle is preference shares.

Tax treatment of each

For the company: Section 56(2)(viib) — the angel tax provision — applies to share issuances above fair market value. CCDs, CCPS and priced equity rounds all need Rule 11UA-compliant valuation reports. SAFE-style instruments, being contractual, technically fall outside Section 56(2)(viib) at issuance — but are caught at conversion when shares are actually issued. DPIIT-recognised startups are exempt from Section 56 on rounds raised from accredited investors, which removes much of the friction.

For the investor: gains on conversion are not a tax event — conversion is treated as cost-substitution. Gains on eventual sale of the equity are capital gains, with the holding period starting from the date of original instrument allotment (CCD/CCPS) or the date of conversion (some interpretations differ here, and this is one of the structural choices that matters at exit).

For the founder: nothing on the company-side issuance, but dilution affects the founder’s eventual capital gains on exit. The lower the conversion price (favourable to investor), the more shares issued, the more founder dilution. Read the cap and discount carefully before signing.

FEMA compliance — especially for foreign investors

Every foreign investment into an Indian company requires FC-GPR filing on the SMF portal within 30 days of allotment, with a Rule 11UA-compliant valuation attached. The instrument must be a permissible vehicle under FEMA NDI Rules — equity, CCD, CCPS or warrants. SAFE and convertible notes are not on this list.

For foreign investors, the conversion trigger and price formula must be specified upfront in the instrument terms — open-ended “next round price” conversion mechanics that are common in US SAFEs do not satisfy FEMA’s pricing guidelines. The conversion terms need to specify a minimum price (the FMV at issuance) below which conversion cannot happen — otherwise the instrument fails the “not less than fair value” pricing rule. This is the single most common FEMA mistake on early-stage Indian convertibles with foreign investors.

Sectoral caps and approval routes also matter. Most startup sectors are 100% automatic — no prior RBI approval needed. But a few (defence, broadcasting, specific media, retail trading, and some others) have caps or require approval. Verify the sector before accepting any foreign cheque.

Three structural traps founders fall into

Mixing instruments in the same round. One investor wants CCDs, another wants CCPS, a third holds out for a SAFE. Founders agree to all three to close the round, and end up with a cap table that requires custom conversion mechanics for each instrument at the next priced round. The fix: standardise on one instrument per round — ideally CCDs at seed, CCPS at Series A onwards.

Open-ended valuation caps. A SAFE or CCD with a ₹100 Cr valuation cap looks reasonable when you raise it. Three years later when you raise Series A at ₹400 Cr, the early investor converts at the cap and ends up with 4× the equity they would have got at Series A pricing. Caps are dilution multipliers — set them with the next two rounds in mind, not just the current one.

Anti-dilution clauses without thresholds or carve-outs. Full-ratchet anti-dilution in any first-round CCPS is a trap — any subsequent down round triggers massive re-pricing in favour of the early investor. Broad-based weighted-average anti-dilution with carve-outs for ESOP issuances and strategic transactions is the Indian standard for a reason. Negotiate the carve-outs as carefully as the formula.

When to use which

SAFE-style: early friends-and-family rounds where everyone is Indian-resident and the cheque is small (under ₹50 lakh per investor). Avoid for foreign investors. Convert into CCDs or CCPS at the first institutional round.

CCD: seed rounds with foreign investors where the round is small-to-medium (₹2-15 Cr), structure is intentionally simple, and rights are minimal. The default choice for most Indian seed rounds.

CCPS: institutional seed and Series A rounds where investors want preference economics, anti-dilution and reserved-matter consent rights. The default for any institutional priced round.

Priced round (via CCPS): Series A onwards where the company has metrics that support a fixed valuation. The cleanest cap-table position, the simplest subsequent-round mechanics, and the structure that scales best toward a future IPO.

Bottom line

The instrument question feels existential to founders raising their first round, but it is mostly resolved by two facts: your investor mix (Indian-resident vs foreign) and your stage (friends-and-family vs institutional). For 80% of Indian founders raising a meaningful first round, the answer is CCDs at seed, CCPS at Series A. The remaining 20% have edge cases — pure US-investor rounds via a Delaware flip, government-grant-led pre-seed, family-office structured deals — that warrant custom design. Avoid SAFE for FEMA-compliant rounds. Negotiate the cap, the discount, and the anti-dilution formula with the next two rounds in mind. And get your Section 42 documentation right — the easiest way to invalidate a perfectly negotiated round is to skip a board resolution or miss a PAS-3 filing.